News

Pozen has initiated the enrollment for the Phase 3 studies for PA32540. PA32540 is a fixed-dose combination of 325mg of enteric coated aspirin and 40mg of immediate release

Soligenix, formerly known as Dor BioPharma, has formed a consortium to develop thermostable technology to advance RiVax and other rapidly acting vaccines. The company has received a $9.4m

Merck & Co has reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of Elonva (corifollitropin alfa

The company believes that the test will provide early and sensitive diagnosis of myocardial infarction and risk stratification for acute coronary syndromes William Moffitt, president and chief executive

Covidien has reported that the FDA has set a new action date, under the Prescription Drug User Fee Act for the review of the New Drug Application (NDA)

Nutra Pharma has introduced Nyloxin OTC, an over-the-counter (OTC) drug for the treatment of chronic pain. Nyloxin OTC will be marketed and sold internationally alongside the company’s prescription

“Despite recent challenges, we have seen several positive signs,” commented Mr. Xiaodong Wu, Chairman and Chief Executive Officer of the Company. “In the past quarter, we received SFDA

BD (Becton, Dickinson and Company) has completed its acquisition of HandyLab, an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. Reportedly, as

Keystone Folding Box has announced the appointment of new director for marketing. Ward Smith, new director, will be responsible for development of compliance packaging and applications for clinical